Glucose Disposal Rate as a Metric for Detection of Metabolic Associated Fatty Liver
NCT06923215 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2025-04-11
Summary
A 12-month prospective observational cohort study assessing eGDR's utility in diagnosing MAFLD (via FibroScan® CAP ≥248 dB/m) and correlating it with steatosis/fibrosis severity. Secondary aims compare eGDR to FLI/FIB-4 scores and identify optimal diagnostic cut-offs
Conditions
- MAFLD
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-30
- Primary Completion
- 2026-11-30
- Completion
- 2026-12-30
More Related Trials
-
Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology.
NCT04435054 ·Status: COMPLETED ·Phase: NA
-
FibroScan-Reproducibility and Repeatability Study
NCT06877026 ·Status: COMPLETED ·Phase: NA
-
Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver Disease
NCT06739330 ·Status: RECRUITING
-
Non-invasive Evaluation of Hepatic Fibrosis in Patients With the Metabolic Syndrome
NCT00399932 ·Status: UNKNOWN
-
Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population
NCT06225193 ·Status: RECRUITING
-
Is There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese Patients
NCT07168551 ·Status: NOT_YET_RECRUITING
-
Changes in Liver Fibrosis, Lipid Profile and Insulin Resistance in HCV Patients Who Received Antiviral Therapy
NCT03612973 ·Status: COMPLETED ·Phase: NA
-
Screening for Liver Fibrosis by Using Non-invasive Methods in Patients With Diabetes. A Prospective Study
NCT01306110 ·Status: COMPLETED
-
Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference.
NCT01985009 ·Status: COMPLETED ·Phase: NA
-
Subclinical Diabetes Confirmed by 75gm-OGTT Influence on the Prognosis of Decompensated Cirrhosis
NCT04828512 ·Status: UNKNOWN
-
A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk Populations
NCT03726827 ·Status: COMPLETED
-
Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus
NCT04232293 ·Status: COMPLETED ·Phase: NA
-
Predictive Power of Share Wave Fibro Scan in HCC After HCV Infection
NCT05105828 ·Status: COMPLETED
-
Non-invasive Assessment of Liver Fibrosis in a French Cohort of Pediatric Patients With Type III Glycogen Storage Disease: Current State and Perspectives
NCT07303140 ·Status: RECRUITING
-
Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in Assiut University Hospitals
NCT04482153 ·Status: UNKNOWN
-
Screening for Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD) at Al-Rajhy Hospital Nutrition Clinic. Assiut, Egypt
NCT04861012 ·Status: UNKNOWN ·Phase: NA
-
Sonoelastography: Ultrasound Method to Measure Liver Fibrosis
NCT01747772 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Ultrasound in Liver Stiffness and Fat Quantification
NCT06111859 ·Status: RECRUITING ·Phase: NA
-
MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients
NCT06492369 ·Status: COMPLETED
-
Impact of Fructose on Metabolism, Energy Homeostasis and Magnetic Resonance Biomarkers in Nonalcoholic Fatty Liver Disease
NCT01930123 ·Status: TERMINATED ·Phase: PHASE2
-
Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver Steatosis
NCT02575625 ·Status: UNKNOWN ·Phase: NA
-
Development of a New Method for Liver Stiffness Measurement Using FibroScan
NCT06519331 ·Status: RECRUITING ·Phase: NA
-
Assessment of Hepatic Steatosis Using Dedicated Software Implemented on Ultrasound Devices
NCT07268937 ·Status: COMPLETED
-
Accurate Point of Care Liver Disease Diagnostics
NCT05986916 ·Status: ACTIVE_NOT_RECRUITING
-
Study Visceral Adipose Tissue and Liver Stifness in a Retrospective Cohort of Diabetes Mellitus Patients
NCT04493814 ·Status: UNKNOWN